TG Therapeutics, Inc. (TGTX)

TG Therapeutics Revenue

In the year 2025, TG Therapeutics had annual revenue of $616.29M with 87.32% growth. TG Therapeutics had revenue of $192.57M in the quarter ending December 31, 2025, with 78.00% growth.

• Revenue (ttm): $616.29M
• Revenue Growth: +87.32%
• P/S Ratio: 8.08
• Revenue / Employee: $1,544,579
• Employees: 399
• Market Cap: 4.98B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	616.29M	287.28M	87.32%
Dec 31, 2024	329.00M	95.34M	40.80%
Dec 31, 2023	233.66M	230.88M	8,290.02%
Dec 31, 2022	2.79M	-3.90M	-58.36%
Dec 31, 2021	6.69M	6.54M	4,300.66%
Dec 31, 2020	152.00K	-	-
Dec 31, 2019	152.00K	-	-
Dec 31, 2018	152.00K	-	-
Dec 31, 2017	152.00K	-	-
Dec 31, 2016	152.00K	-381.00	-0.25%
Dec 31, 2015	152.38K	-	-
Dec 31, 2014	152.38K	-	-
Dec 31, 2013	152.38K	133.33K	699.98%
Dec 31, 2012	19.05K	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	-	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-